LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 45 pages found matching Zetia- Zetia heart attack may result in lawsuit
Zetia , an anti-hyperlipidemic drug, is prescribed to treat high cholesterol. Since its FDA approval in 2002, serious Zetia side effects have been reported, including Zetia liver and Zetia heart attack problems. These Zetia problems have led to a number of Zetia lawsuits . Zetia is also used in conjunction with statins to lower cholesterol, but it has... - Ezetrol Heart Attack and Stroke Legal Help
Merck and Shering-Plough have announced that, based on a study of 720 patients, Vytorin, which combines Zetia (Ezetimibe) and Zocor (Simvastatin), does not reduce the growth of fatty arterial plaque. Rather, patients who took Vytorin had more plaque growth than patients who took only Zocor. In Canada, the drug Zetia is known as Ezetrol and is developed, m... - Statins Star Rises, But Zetia?
Jan-11-08 Kenilworth, NJ: The outlook on cholesterol-fighting statins only gets better, while cholesterol drug Zetia continues to be cloaked in a shroud of secrecy. At issue is a study on Zetia's safety and effectiveness that was completed two years ago by Merck and Schering-Plough, but was never released. The so-called Enhance study, which should give the best in... - Zetia and Vytorin Continue to be Controversial
Aug-28-17 Washington, DC: There is little doubt that the cholesterol-fighting drug Zetia (ezetimibe) has travelled a rocky road since it was first approved by the US Food and Drug Administration (FDA) in 2002. And while several years have passed since the controversial delay in releasing study results into potential Zetia side effects , issues involving Zetia and... - Zetia: So Many Questions, So Few Answers
Dec-26-07 Kenilworth, NJ In the five years since cholesterol drug Zetia has been on the market, millions of Americans have embraced Zetia to help them control their cholesterol levels. And yet, the safety of Zetia, and specifically concerns surrounding the potential for liver damage has been suspected for some time. In fact, prior to Zetia gaining US Food a... - Ayuda Legal Para Victimas de Ataque Cardiaco (Infarto) o Derrame Cerebral por Ezetrol
Merck y Shering-Plough han anunciado que, sobre la base de un estudio de 720 pacientes, Vytorin, que combina Zetia (Ezetimiba) y Zocor (simvastatina), no reduce el crecimiento de la placa arterial grasosa. Por lo contrario, los pacientes que tomaron Vytorin tenian más crecimiento de placa que los pacientes que tomaron este fármaco sólo. En Canadá, la dro... - Zetia can have Serious Side Effects
Jan-5-08 Seattle, WA: Patients taking Zetia are now learning that the drug may come with some serious side effects. Those include liver damage, rhabdomyolysis and myopathy. What has surprised many consumers is that the makers of Zetia conducted a few studies and found that there are risks associated with taking Zetia, but did not publicize the results of those st... - Vytorin Liver Damage and Heart Attack Risk
Vytorin , a drug prescribed to treat high cholesterol, is a combination of the cholesterol-lowering Zetia and the statin Zocor. Since its FDA approval in 2004, serious Vytorin side effects have been reported, including Vytorin liver problems and statin cardiomyopathy , which can lead to Vytorin heart attack. Furthermore, the ENHANCE study in 2008 showed... - Ezetrol: Zetia by Any Other Name...
Feb-25-08 Toronto, ON Canadian visitors to LawyersAndSettlements may wonder about all the recent uproar around Zetia , Merck Pharmaceuticals' costly and quite possibly ineffective anti-cholesterol drug, and its offshoot Vytorin , the combination Zetia/simvastatin (Zocor) drug produced jointly by Merck/Schering-Plough. Vytorin, of course, was the subject of the rec... - Zetia: Feds Order Early Release of Enhance Trial Data
Jan-4-08 Whitehouse Station, NJ: A study into the effectiveness of cholesterol drug Zetia completed months ago may shed new light on the true effectiveness of the Shering-Plough and Merck product, and the potential for liver damage. However, the manufacturer has been dragging its heels, so much so that the investigations subcommittee of the House Energy and Comme... - Zetia: How Did It Get Here?
Feb-18-08 Washington, DC The emerging scandal surrounding Merck/Schering-Plough's Zetia and Vytorin cholesterol-lowering drugs has raised questions about some related issues. To recap: on January 14, after nearly a two-year delay, Merck/Schering released the results of its ENHANCE testing program for their combination Zetia/simvastatin (Zocor) drug called Vytori... - Of All Vytorin Side Effects, Potential for Cancer Is Getting Traction
Aug-31-14 Washington, DC One can’t help but forgive anyone filing a Vytorin lawsuit, due to not only the potential for various harms related to possible Vytorin side effects , but to the very culture that sees drugs such as these approved in the first place. Vytorin, as most familiar with the file are aware, is a combination of two drugs: Zetia (ezetimib... - Zetia and/or Statins: The Good, the Bad and the Ugly
Apr-14-11 Halle-Wittenberg, Germany Can a drug designed to curb heart attacks also cause heart attacks in some people? Apparently, it's possible with statins or medication like Zetia when used in combination with a statin. Statins are designed to lower the "bad" cholesterol thought to be a contributing factor for heart attack and stroke, while leaving the so-cal... - Ezetrol: Canadian Version of Zetia Questioned
Mar-9-08 Toronto, ON As if the Zetia and Vytorin issue wasn't enough of a frustration on its own, north of the border in Canada the Canadian equivalent of Zetia— Ezetrol —is proving just as mystifying. At issue: does the cholesterol drug work? Is it harmful? And did the manufacturer, as it was accused of doing in the US, withhold important safety a... - ARBITER 6-HALTS Results Not Good for Zetia
Nov-17-09 Houston, TX Results of the ARBITER 6-HALTS trial of Zetia (ezetimibe) and Niaspan (niacin) show that Niaspan is more effective than Zetia as a cholesterol treatment. This news has caused some doctors to question whether or not to use Zetia to treat patients with high cholesterol. The results were published along with two editorials in the New England... - More Controversy Surrounding Zetia
Jan-13-08 New York, NY: When the makers of Zetia announced that they were changing the goals of a clinical trial of the drug, after the trial had already been started, the companies faced a great deal of criticism. According to an article in Forbes, the situation was actually more controversial than that. The reason is that, according to Forbes, when the comp... - Vytorin Fraudulent Marketing Class Action Lawsuit
The makers of the cholesterol drug Vytorin are under fire for allegedly making false claims in their marketing campaign. New York Attorney-General Andrew Cuomo is investigating whether Vytorin's marketing campaign violated the state's laws regarding false advertising. Specifically, officials are concerned that, despite results from a study that found Vytorin... - Zocor Side Effects
The Zocor cholesterol drug, a member of the class of drugs known as statins, is prescribed to many people with high cholesterol when diet and exercise are inadequate. Since 2002, the FDA has issued warnings about Zocor liver damage and increased Zocor myopathy (muscle damage) associated with statins. A recent Zocor SEARCH study shows that higher doses o... - Zetia/Vytorin: "I can't afford to take any more chances."
Jan-30-08 Huntington Beach, CA: George Stavros fits the profile of someone who would be prescribed Merck/Schering-Plough's Zetia anti-cholesterol drug to help prevent a possible heart attack. The question is whether it did him more harm than good. Stavros (not his real name pending possible legal action) has a history of cardiovascular disease dating back to 19... - Zetia/Vytorin Manufacturers Pull TV Ads
Jan-24-08 Kenilworth, NJ: Merck/Schering-Plough announced on Tuesday January 22, that they are pulling all direct-to-consumer (DTC) television advertisements for their Zetia and Vytorin products. Zetia is Merck/Schering's branded anti-cholesterol drug which is also used in Vytorin, which contains Zetia and the statin drug Zocor (simvastation). Merck/Schering's...